{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:35:47Z","timestamp":1792643747581,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1023\/a:1013746828074","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T17:20:10Z","timestamp":1040664010000},"page":"419-426","source":"Crossref","is-referenced-by-count":89,"title":["Porphyria Cutanea Tarda: Multiplicity of Risk Factors Including HFE Mutations, Hepatitis C, and Inherited Uroporphyrinogen Decarboxylase Deficiency"],"prefix":"10.1007","volume":"47","author":[{"given":"Norman G.","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Goeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil P.","family":"Miskovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Weinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"367768_CR1","first-page":"2991","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"KE Anderson","year":"2001","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ: Disorders of heme biosynthesis: X-linked sideroblastic anemias and the porphyrias. In The Metabolic and Molecular Basis of Inherited Disease. CR Scriver, AL Beaudet, WS Sly, D Valle, B Childs, B Vogelstein (eds). New York, McGraw-Hill, 2001 In press Chapter 124, pp 2991\u20133062"},{"key":"367768_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","volume":"18","author":"GH Elder","year":"1998","unstructured":"Elder GH: Porphyria cutanea tarda. Semin Liver Dis 18:67\u201375, 1998","journal-title":"Semin Liver Dis"},{"key":"367768_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","volume":"2","author":"GH Elder","year":"1985","unstructured":"Elder GH, Urquhart AJ, de Salamanca RE, Munoz JJ, Bonkovsky HL: Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 2:229\u2013233, 1985","journal-title":"Lancet"},{"key":"367768_CR4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.510270237","volume":"27","author":"MJ Moran","year":"1998","unstructured":"Moran MJ, Fontanellas A, Brudieux E, Hombrados I, de Ledinghen V, Couzigou P, de Verneuil H, De Salamanca RE: Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection. Hepatology 27:584\u2013589, 1998","journal-title":"Hepatology"},{"key":"367768_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-5793(88)80449-6","volume":"233","author":"JE Francis","year":"1988","unstructured":"Francis JE, Smith AG: Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase. FEBS Lett 233:311\u2013314, 1988","journal-title":"FEBS Lett"},{"key":"367768_CR6","first-page":"437","volume-title":"Hepatotoxicology","author":"F De Matteis","year":"1991","unstructured":"De Matteis F: Drug induced abnormalities of liver heme biosynthesis. In Hepatotoxicology. RG Meeks, SD Harrison, RJ Bull (eds). Boca Raton, Florida, CRC Press, 1991, pp 437\u2013479"},{"key":"367768_CR7","first-page":"362","volume":"87","author":"MB Poh-Fitzpatrick","year":"1976","unstructured":"Poh-Fitzpatrick MB, Lamola AA: Direct spectrophotometry of diluted erythrocytes and plasma: A rapid diagnostic method in primary and secondary porphyrinemias. J Lab Clin Med 87:362\u2013370, 1976","journal-title":"J Lab Clin Med"},{"key":"367768_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.1980.01640290053010","volume":"116","author":"MB Poh-Fitzpatrick","year":"1980","unstructured":"Poh-Fitzpatrick MB: A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 116:543\u2013547, 1980","journal-title":"Arch Dermatol"},{"key":"367768_CR9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000139403","volume":"52","author":"NG Egger","year":"1996","unstructured":"Egger NG, Pow-Sang M, Johnson SA, Motamedi M, Anderson KE, Orihuela E: Accumulation of porphyrins in plasma and tissues of dogs after \u03b4-aminolevulinic acid administration: Implications for photodynamic therapy. Pharmacology 52:362\u2013370, 1996","journal-title":"Pharmacology"},{"key":"367768_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0021-9258(18)65809-0","volume":"219","author":"D Mauzerall","year":"1956","unstructured":"Mauzerall D, Granick S: The occurrence and determination of _-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 219:435\u2013446, 1956","journal-title":"J Biol Chem"},{"key":"367768_CR11","first-page":"156","volume":"8","author":"S Schwartz","year":"1976","unstructured":"Schwartz S, Edmondson P, Stephenson B, Sarkar D, Freyholtz H: Direct spectrofluorophotometric determination of porphyrin in diluted urine. Ann Clin Res 8:156\u2013161, 1976","journal-title":"Ann Clin Res"},{"key":"367768_CR12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/clinchem\/31.7.1163","volume":"31","author":"WH Lockwood","year":"1985","unstructured":"Lockwood WH, Poulos V, Rossi E, Curnow DH: Rapid procedure for fecal porphyrin assay. Clin Chem 31:1163\u20131167, 1985","journal-title":"Clin Chem"},{"key":"367768_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-2797(96)03732-5","volume":"102","author":"NG Egger","year":"1996","unstructured":"Egger NG, Goeger DE, Anderson KE: Effects of chloroquine in hematoporphyrin-treated animals. Chem-Biol Interact 102:69\u201378, 1996","journal-title":"Chem-Biol Interact"},{"key":"367768_CR14","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/clinchem\/34.11.2355","volume":"34","author":"J McManus","year":"1988","unstructured":"McManus J, Blake D, Ratnaike S: An assay of uroporphyrinogen decarboxylase in erythrocytes. Clin Chem 34:2355\u20132357, 1988","journal-title":"Clin Chem"},{"key":"367768_CR15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(79)90403-0","volume":"67","author":"ME Grossman","year":"1979","unstructured":"Grossman ME, Bickers DR, Poh-Fitzpatrick MB, DeLeo VA, Harber LC: Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med 67:277\u2013286, 1979","journal-title":"Am J Med"},{"key":"367768_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-2143(97)90096-2","volume":"130","author":"PR Sinclair","year":"1997","unstructured":"Sinclair PR, Gorman G, Shedlofsky SI, Honsinger C, Sinclair JF, Karagas MR, Anderson KE: Ascorbic acid deficiency in porphyria cutanea tarda. J Lab Clin Med 130:197\u2013201, 1997","journal-title":"J Lab Clin Med"},{"key":"367768_CR17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2362.1995.tb01737.x","volume":"25","author":"E Rocchi","year":"1995","unstructured":"Rocchi E, Stella AM, Cassanelli M, Borghi A, Nardella N, Seium Y, Caselgrande G: Liposoluble vitamins and naturally occurring carotenoids in porphyria cutanea tarda. Eur J Clin Invest 25:510\u2013514, 1995","journal-title":"Eur J Clin Invest"},{"key":"367768_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0891-5849(96)00044-5","volume":"21","author":"N De Maria","year":"1996","unstructured":"De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, Floyd RA: Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 21:291\u2013295, 1996","journal-title":"Free Radic Biol Med"},{"key":"367768_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-2952(93)90407-N","volume":"46","author":"W Van Gelder","year":"1993","unstructured":"Van Gelder W, Siersema PD, Voogd A, De Jeu-Jaspars NCM, Van Eijk HG, Koster JF, De Rooy FWM, Wilson JHP: The effect of desferrioxamine on iron metabolism and lipid peroxidation in hepatocytes of C57BL\/10 mice in experimental uroporphyria. Biochem Pharmacol 46:221\u2013228, 1993","journal-title":"Biochem Pharmacol"},{"key":"367768_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0891-5849(89)90033-6","volume":"7","author":"AI Cederbaum","year":"1989","unstructured":"Cederbaum AI: Oxygen radical generation by microsomes: Role of iron and implications for alcohol metabolism and toxicity. Free Radic Biol Med 7:559\u2013567, 1989","journal-title":"Free Radic Biol Med"},{"key":"367768_CR21","doi-asserted-by":"crossref","first-page":"S1256","DOI":"10.1093\/ajcn\/54.6.1256s","volume":"54","author":"JG Liehr","year":"1991","unstructured":"Liehr JG: Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol. Am J Clin Nutr 54:S1256\u2013S1260, 1991","journal-title":"Am J Clin Nutr"},{"key":"367768_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0006-2952(97)00141-X","volume":"54","author":"N Legault","year":"1997","unstructured":"Legault N, Sabik H, Cooper SF, Charbonneau M: Effect of estradiol on the induction of porphyria by hexachlorobenzene in the rat. Biochem Pharmacol 54:19\u201325, 1997","journal-title":"Biochem Pharmacol"},{"key":"367768_CR23","doi-asserted-by":"crossref","first-page":"378A","DOI":"10.1016\/0270-9139(95)95233-0","volume":"22","author":"KE Anderson","year":"1995","unstructured":"Anderson KE, Vadhanavikit S, Goeger DE: Estrogen and antioxidants in hexachlorobenzene-induced hepatic porphyria in rats. Hepatology 22:378A, 1995 (abstract)","journal-title":"Hepatology"},{"key":"367768_CR24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/abbi.1993.1376","volume":"304","author":"PR Sinclair","year":"1993","unstructured":"Sinclair PR, Gorman N, Walton HS, Bement WJ, Jacobs JM, Sinclair JF: Ascorbic acid inhibition of cytochrome P-450-catalyzed uroporphyrin accumulation. Arch Biochem Biophys 304:464\u2013470, 1993","journal-title":"Arch Biochem Biophys"},{"key":"367768_CR25","first-page":"565","volume":"22","author":"PR Sinclair","year":"1995","unstructured":"Sinclair PR, Gorman N, Sinclair JF, Walton HS, Bement WJ, Lambrecht RW: Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats. Hepatology 22:565\u2013572, 1995","journal-title":"Hepatology"},{"key":"367768_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-291X(87)90683-8","volume":"146","author":"JE Francis","year":"1987","unstructured":"Francis JE, Smith AG: Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL\/10 mice: Comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations. Biochem Biophys Res Commun 146:13\u201320, 1987","journal-title":"Biochem Biophys Res Commun"},{"key":"367768_CR27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0026-895X(25)13332-4","volume":"33","author":"F De Matteis","year":"1988","unstructured":"De Matteis F: Role of iron in the hydrogen peroxidedependent oxidation of hexahydroporphyrins (porphyrinogens): A possible mechanism for the exacerbation by iron of hepatic uroporphyria. Molec Pharmacol 33:463\u2013469, 1988","journal-title":"Molec Pharmacol"},{"key":"367768_CR28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-5793(89)80753-7","volume":"250","author":"JM Jacobs","year":"1989","unstructured":"Jacobs JM, Sinclair PR, Lambrecht RW, Sinclair JF: Effects of iron-EDTA on uroporphyrinogen oxidation by liver microsomes. FEBS Lett 250:349\u2013352, 1989","journal-title":"FEBS Lett"},{"key":"367768_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0003-9861(92)90717-B","volume":"294","author":"RW Lambrecht","year":"1992","unstructured":"Lambrecht RW, Sinclair PR, Gorman N, Sinclair JF: Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P-450IA2. Arch Biochem Biophys 294:504\u2013510, 1992","journal-title":"Arch Biochem Biophys"},{"key":"367768_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj3300149","volume":"330","author":"PR Sinclair","year":"1998","unstructured":"Sinclair PR, Gorman N, Dalton T, Walton HS, Bement WJ, Sinclair JF, Smith AG, Nebert DW: Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-\/-) null mutant mice. Biochem J 330:149\u2013153, 1998","journal-title":"Biochem J"},{"key":"367768_CR31","first-page":"1019","volume":"26","author":"PR Sinclair","year":"1998","unstructured":"Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF: Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos 26:1019\u20131025, 1998","journal-title":"Drug Metab Dispos"},{"key":"367768_CR32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","volume":"16","author":"S Fargion","year":"1992","unstructured":"Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis-C virus and porphyria cutanea tarda\u2014 evidence of a strong association. Hepatology 16:1322\u20131326, 1992","journal-title":"Hepatology"},{"key":"367768_CR33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hep.1840170405","volume":"17","author":"M DeCastro","year":"1993","unstructured":"DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, Garcia-Monzon C, Sequi J, Moreno-Otero R: Hepatitis-C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 17:551\u2013557, 1993","journal-title":"Hepatology"},{"key":"367768_CR34","first-page":"279","volume":"21","author":"S Navas","year":"1995","unstructured":"Navas S, Bosch O, Castillo I, Marriott E, Carreno V: Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study. Hepatology 21:279\u2013284, 1995","journal-title":"Hepatology"},{"key":"367768_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0190-9622(99)70402-0","volume":"41","author":"TY Chuang","year":"1999","unstructured":"Chuang TY, Brashear R, Lewis C: Porphyria cutanea tarda and hepatitis C virus: A case\u2014control study and meta-analysis of the literature. J Am Acad Dermatol 41:31\u201336, 1999","journal-title":"J Am Acad Dermatol"},{"key":"367768_CR36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","volume":"27","author":"HL Bonkovsky","year":"1998","unstructured":"Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW: Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 27:1661\u20131669, 1998","journal-title":"Hepatology"},{"key":"367768_CR37","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","volume":"95","author":"ZJ Bulaj","year":"2000","unstructured":"Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP: Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95:1565\u20131571, 2000","journal-title":"Blood"},{"key":"367768_CR38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.1840210604","volume":"21","author":"U Stolzel","year":"1995","unstructured":"Stolzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Somasundaram R, Doss MO, Habermehl KO, Riecken EO: Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500\u20131503, 1995","journal-title":"Hepatology"},{"key":"367768_CR39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0676.1992.tb00557.x","volume":"12","author":"PD Siersema","year":"1992","unstructured":"Siersema PD, ten Kate FJ, Mulder PG, Wilson JH: Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 12:56\u201361, 1992","journal-title":"Liver"},{"key":"367768_CR40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.2830250112","volume":"25","author":"PS Wissel","year":"1987","unstructured":"Wissel PS, Sordillo P, Anderson KE, Sassa S, Savillo RL, Kappas A: Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol 25:107\u2013113, 1987","journal-title":"Am J Hematol"},{"key":"367768_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000247768","volume":"182","author":"AM Boisseau","year":"1991","unstructured":"Boisseau AM, Couzigou P, Forestier JF, Legrain V, Aubertin J, Doutre MS, Maleville J, Geniaux M, Beylot C: Porphyria cutanea tarda associated with human immunodeficiency virus infection. A study of four cases and review of the literature. Dermatologica 182:155\u2013159, 1991","journal-title":"Dermatologica"},{"key":"367768_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/clinids\/20.2.348","volume":"20","author":"F McAlister","year":"1995","unstructured":"McAlister F, McClean K, Hamilton PG, Houston S: Human immunodeficiency virus infection and porphyria cutanea tarda: Coexistence of risk factors or causative association? Clin Infect Dis 20:348\u2013351, 1995","journal-title":"Clin Infect Dis"},{"key":"367768_CR43","first-page":"492","volume":"8","author":"C Drobacheff","year":"1998","unstructured":"Drobacheff C, Derancourt C, Van Landuyt H, Devred D, de Wazieres B, Cribier B, Rey D, Lang JM, Grosieux C, Kalis B, Laurent R: Porphyria cutanea tarda associated with human immunodeficiency virus infection. Eur J Dermatol 8:492\u2013496, 1998","journal-title":"Eur J Dermatol"},{"key":"367768_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9629(15)40629-9","volume":"318","author":"VJ Felitti","year":"1999","unstructured":"Felitti VJ, Beutler E: New developments in hereditary hemochromatosis. Am J Med Sci 318:257\u2013268, 1999","journal-title":"Am J Med Sci"},{"key":"367768_CR45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(99)70244-1","volume":"116","author":"BR Bacon","year":"1999","unstructured":"Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH: Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 116:193\u2013207, 1999","journal-title":"Gastroenterology"},{"key":"367768_CR46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0016-5085(99)70134-4","volume":"116","author":"R Moirand","year":"1999","unstructured":"Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier Y: Phenotypic expression of HFE mutations: A French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 116:372\u2013377, 1999","journal-title":"Gastroenterology"},{"key":"367768_CR47","doi-asserted-by":"crossref","unstructured":"A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium. Gut 41:841\u2013844, 1997","DOI":"10.1136\/gut.41.6.841"},{"key":"367768_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.1998.tb03683.x","volume":"54","author":"W Burke","year":"1998","unstructured":"Burke W, Press N, McDonnell SM: Hemochromatosis: Genetics helps to define a multifactorial disease. Clin Genet 54:1\u20139, 1998","journal-title":"Clin Genet"},{"key":"367768_CR49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/bcmd.1999.0264","volume":"25","author":"N Arya","year":"1999","unstructured":"Arya N, Chakrabrati S, Hegele RA, Adams PC: HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors. Blood Cells Mol Dis 25:354\u2013357, 1999","journal-title":"Blood Cells Mol Dis"},{"key":"367768_CR50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/bcmd.1999.0240","volume":"25","author":"JC Barton","year":"1999","unstructured":"Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT: Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 25:147\u2013155, 1999","journal-title":"Blood Cells Mol Dis"},{"key":"367768_CR51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/bcmd.1999.0265","volume":"25","author":"E Beutler","year":"1999","unstructured":"Beutler E, Felitti VJ, Ho NJ, Gelbart T: Commentary on HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors by Naveen Arya, Subrata Chakrabrati, Robert A. Hegele, Paul C. Adams. Blood Cells Mol Dis 25:358\u2013360, 1999","journal-title":"Blood Cells Mol Dis"},{"key":"367768_CR52","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/clinchem\/45.12.2275","volume":"45","author":"M Bollhalder","year":"1999","unstructured":"Bollhalder M, Mura C, Landt O, Maly FE: LightCycler PCR assay for simultaneous detection of the H63D and S65C mutations in the HFE hemochromatosis gene based on opposite melting temperature shifts. Clin Chem 45:2275\u20132278, 1999","journal-title":"Clin Chem"},{"key":"367768_CR53","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1182\/blood.V93.8.2502","volume":"93","author":"C Mura","year":"1999","unstructured":"Mura C, Raguenes O, Ferec C: HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502\u20132505, 1999","journal-title":"Blood"},{"key":"367768_CR54","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0016-5085(99)70505-6","volume":"116","author":"DF Wallace","year":"1999","unstructured":"Wallace DF, Dooley JS, Walker AP: A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology 116:1409\u20131412, 1999","journal-title":"Gastroenterology"},{"key":"367768_CR55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","volume":"349","author":"AG Roberts","year":"1997","unstructured":"Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH: Increased frequency of haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321\u2013323, 1997","journal-title":"Lancet"},{"issue":"S","key":"367768_CR56","first-page":"114","volume":"98","author":"H Jackson","year":"1997","unstructured":"Jackson H, Whatley SD, Morgan RR, Roberts AG, Worwood M, Elder GH: The haemochromatosis C282Y mutation in sporadic and familial porphyria cutanea tarda. Acta Haematol 98(S):114, 1997 (abstract)","journal-title":"Acta Haematol"},{"key":"367768_CR57","first-page":"159","volume":"25","author":"AG Roberts","year":"1997","unstructured":"Roberts AG, Whatley SD, Nicklin S, Worwood M, Pointon JJ, Stone C, Elder GH: The frequency of hemochromatosisassociated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 25:159\u2013161, 1997","journal-title":"Hepatology"},{"key":"367768_CR58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0168-8278(98)80313-9","volume":"28","author":"KA Stuart","year":"1998","unstructured":"Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH: The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 28:404\u2013409, 1998","journal-title":"J Hepatol"},{"key":"367768_CR59","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJM199705013361817","volume":"336","author":"M Santos","year":"1997","unstructured":"Santos M, Clevers HC, Marx JJ: Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl J Med 336:1327\u20131328, 1997 (letter)","journal-title":"N Engl J Med"},{"key":"367768_CR60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.510270128","volume":"27","author":"M Sampietro","year":"1998","unstructured":"Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, Malosio I, Mattioli M, Fracanzani AL, Cappellini MD, Fiorelli G, Fargion S: High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27:181\u2013184, 1998","journal-title":"Hepatology"},{"key":"367768_CR61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.510300320","volume":"30","author":"R Enriquez de Salamanca","year":"1999","unstructured":"Enriquez de Salamanca R, Morales P, Castro MJ, Rojo R, Gonzalez M, Arnaiz-Villena A: The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp. Hepatology 30:819\u2013820, 1999 (letter)","journal-title":"Hepatology"},{"key":"367768_CR62","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.510270631","volume":"27","author":"BC Smith","year":"1998","unstructured":"Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF: Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27:1695\u20131699, 1998","journal-title":"Hepatology"},{"key":"367768_CR63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(99)70236-2","volume":"116","author":"L Kazemi-Shirazi","year":"1999","unstructured":"Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P: The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127\u2013134, 1999","journal-title":"Gastroenterology"},{"key":"367768_CR64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0016-5085(93)90022-5","volume":"105","author":"JR Garey","year":"1993","unstructured":"Garey JR, Franklin KF, Brown DA, Harrison LM, Metcalf KM, Kushner JP: Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology 105:165\u2013169, 1993","journal-title":"Gastroenterology"},{"key":"367768_CR65","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.510300626","volume":"30","author":"A Ivanova","year":"1999","unstructured":"Ivanova A, von Ahsen N, Adjarov D, Krastev Z, Oellerich M, Wieland E: C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria. Hepatology 30:1531\u20131532, 1999 (letter)","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1013746828074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1013746828074\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1013746828074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T02:54:26Z","timestamp":1753757666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1013746828074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["367768"],"URL":"https:\/\/doi.org\/10.1023\/a:1013746828074","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}